Systemic Diseases and the Pleura;Enfermedades sistémicas y pleura

Archivos de Bronconeumologia

Volumn 47, Issue 7, 2011, Pages 361-370

  Ferreiro, Lucía ^a   Álvarez Dobaño, José Manuel ^a   Valdés, Luis ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

Connective tissue diseases; Pleural disease; Systemic diseases; Vasculitis

Indexed keywords

ADJUVANT DISEASE; CHURG STRAUSS SYNDROME; DIFFERENTIAL DIAGNOSIS; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; OUTCOME ASSESSMENT; PLEURA EFFUSION; SHORT SURVEY; SYSTEMIC DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; WEGENER GRANULOMATOSIS; ADULT ONSET STILL DISEASE; ANGIOIMMUNOBLASTIC T CELL LYMPHOMA; ANKYLOSING SPONDYLITIS; BEHCET DISEASE; DERMATOMYOSITIS; EOSINOPHILIA MYALGIA SYNDROME; EOSINOPHILIC FASCIITIS; GIANT CELL ARTERITIS; MIXED CONNECTIVE TISSUE DISEASE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PLEURA; PLEURA DISEASE; POLYARTERITIS NODOSA; POLYMYOSITIS; RHEUMATOID ARTHRITIS; SARCOIDOSIS; SJOEGREN SYNDROME; SYSTEMIC SCLEROSIS;

EID: 79959304231     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/j.arbr.2011.02.009     Document Type: Short Survey

References (165)

1. Antony V.B. Immunological mechanisms in pleural disease. Eur Respir J. 2003, 21:539-544.
2. Halla J.T., Schrohenloher R.E., Volanakis J.E. Immune complexes and other laboratory features of pleural effusions. Ann Intern Med. 1980, 92:748-752.
3. Koster F.T., McGregor D.D., Mackaness G.B. The mediator of cellular immunity: II. Migration of immunologically committed lymphocytes into inflammatory exudates. J Exp Med. 1971, 133:400-409.
4. Valdés L., Álvarez D., Valle J.M., Pose A., San José E. The etiology of pleural effusions in an area with high incidence of tuberculosis. Chest. 1996, 109:158-162.
5. Villena V., López Encuentra A., Echave-Sustaeta J., Álvarez Martínez C., Martín Escribano P. Estudio prospectivo de 1.000 pacientes consecutivos con derrame pleural. Etiología del derrame y características de los pacientes. Arch Bronconeumol. 2002, 38:21-26.
6. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Reum. 1988, 31:315-324.
7. Klareskog L., Catrina A.I., Paget S. Rheumatoid Arthritis. Lancet 2009, 373:659-672.
8. Cohen M., Sahn S.A. Resolution of pleural effusions. Chest. 2001, 119:1547-1562.
9. Juric A.G., Davidsen D., Graudal H. Prevalence of pulmonary involvement in rheumatoid arthritis and its relationship to some characteristics of the patients. A radiological and clinical study. Scand J Rheumatol. 1982, 11:217-224.
10. Helmers R., Galvin J., Hunninghake G.W. Pulmonary manifestations associated with rheumatoid arthritis. Chest. 1991, 100:235-238.
11. Juric A.G., Graudal H. Pleurisy in rheumatoid arthritis. Scand J Rheumatol. 1983, 12:75-80.
12. Faurschou P., Fransis D., Faarup P. Thoracoscopic, histological, and clinical findings in nine case rheumatoid pleural effusion. Thorax. 1985, 40:371-375.
13. Hakala M., Tiilikainen A., Hameenkorpi R., Ilonen J., Jalava S., Ruuska P., et al. Rheumatoid arthritis with pleural effusions includes a subgroup with autoimmune features and HLA-8, Dw3 association. Scand J Rheumatoil. 1986, 15:290-296.
14. Fernández-Muixi J., Vidal F., Razquin S., Torre L., Richart C. Pleural effusion as initial presentation of rheumatoid arthritis. Cytological diagnosis. Arch Bronconeumol. 1996, 32:427-429.
15. Lillington G.A., Carr D.T., Mayne J.G. Rheumatoid pleurisy with effusion. Arch Intern Med. 1971, 128:764-768.
16. Tanoue L.T. Pulmonary manifestations of rheumatoid arthritis. Clin Chest Med. 1998, 19:667-685.
17. Joseph J., Sahn S.A. Connective tissue disease and the pleura. Chest. 1993, 104:262-270.
18. Sahn S.A., Kaplan R.L., Maulitz R.M., Good J.T. Rheumatoid pleurisy. Observations on the development of low pleural fluid and glucose level. Arch Intern Med. 1980, 140:1237-1238.
19. Dodson W.H., Hollingsworth J.W. Pleural effusion in rheumatoid arthritis impaired transport of glucose. N Engl J Med. 1966, 275:1337-1342.
20. Halla J.T., Schrohenloher R.E., Koopman W.J. Local immune responses in certain extra-articular manifestations of rheumatoid arthritis. Ann Rheum Dis. 1992, 51:698-701.
21. Dieppe P.A. Empyema in rheumatoid arthritis. Ann Rheum Dis. 1975, 34:181-185.
22. Jones F.L., Blodgett R.C. Empyema in rheumatoid pleuropulmonary disease. Ann Intern Med. 1971, 74:665-6671.
23. Houston M.C. Pleural fluid pH: diagnostic, therapeutic, and prognostic value. Am J Surg. 1987, 154:333-337.
24. Wrightson J.M., Stanton A.E., Maskell N.A., Davies R.J.O., Gary Lee Y.C. Pseudochylothorax without pleural thickening. Time to reconsider pathogenesis. Chest. 2009, 136:1144-1147.
25. Hillerdal G. Chylothorax and pseudochylothorax. Eur Respir J. 1997, 10:1157-1162.
26. Huggins J.T. Chylothorax and cholesterol pleural effusion. Semin Respir Crit Care Med. 2010, 31:743-750.
27. Calatayud J., Candelas G., Gómez A., Morado C., Trancho F.H. Nodular pulmonary amyloidosis in a patient with rheumatoid arthritis. Clin Rheumatol. 2007, 26:1797-1798.
28. Lee S.S., Trimble R.B. Rheumatoid arthritis with bloody and cholesterol pleural effusion. Arch Pathol Lab Med. 1985, 109:769-771.
29. Salomaa E.R., Viander M., Saaresranta T., Terho E.O. Complement components and their activation products in pleural fluid. Chest. 1998, 114:723-730.
30. Klockars M., Weber T., Tanner P., Hellstrom P.E., Pettersson T. Pleural fluid ferritin concentrations in human disease. J Clin Pathol. 1985, 38:818-824.
31. Söderblom T., Nyberg P., Pettersson T., Klockars M., Riska H. Pleural fluid beta-2-microglobulin and angiotensin-converting enzyme concentrations in rheumatoid arthritis and tuberculosis. Respiration. 1996, 63:272-276.
32. Nyberg P., Söderblom T., Pettersson T., Riska H., Klockars M., Linko L. Neurone-specific enolase levels in pleural effusions in patients with rheumatoid arthritis. Thorax. 1996, 51:92-94.
33. Söderblom T., Pettersson T., Nyberg P., Teppo A.M., Linko L., Riska H. High pleural fluid hyaluronan concentrations in rheumatoid arthritis. Eur Respir J. 1999, 13:519-522.
34. Pettersson T., Klockars M., Hellstrom P.E. Chemical and immunological features of pleural effusions: comparison between rheumatoid arthritis and other diseases. Thorax. 1982, 37:354-361.
35. Pettersson T., Ojala K., Weber T.H. Adenosine deaminase in the diagnosis of pleural effusions. Acta Med Scand. 1984, 215:299-304.
36. Balbir-Gurman A., Yigla M., Nahir A.M., Braun-Moscovici Y. Rheumatoid pleural effusion. Semin Arthritis Rheum. 2006, 35:368-378.
37. Naylor B. The pathognomonic cytologic picture of rheumatoid pleuritis. Acta Cytol. 1990, 34:465-473.
38. Sahn S.A. Immunologic disease of the pleura. Clin Chest Med. 1985, 6:83-101.
39. Antin-Ozerkis D., Evans J., Rubinowitz A., Homer R.J., Matthay R.A. Pulmonary manifestations of rheumatoid arthritis. Clin Chest Med. 2010, 31:451-478.
40. Sahn S.A. The pleura. Am Rev Respir Dis. 1988, 138:184-234.
41. Chapman P.T., OóDonnell J.L., Moller P.W. Rheumatoid pleural effusion: response to intrapleural corticosteroid. J Rheumatol. 1992, 19:478-480.
42. Huggins J.T., Sahn S.A., Heidecker J., Ravenel J.G., Doelken P. Characteristics of trapped lung. Pleural fluid analysis, manometry, and air-contrast chest CT. Chest. 2007, 131:206-213.
43. Yarbrough J.W., Sealy W.C., Miller J.A. Thoracic surgical problems associated with rheumatoid arthritis. J Thorac Cardiovasc Surg. 1975, 69:347-354.
44. Rueth R., Andrade R., Groth S., D'Cunha J., Maddaus M. Pleuropulmonary complications of rheumatoid arthritis: a thoracic surgeon's challenge. Ann Thorac Surg. 2009, 88:e20-e21.
45. Koegelenberg C.F., Diaconi A.H., Bolligeri C.T. Parapneumonic pleural effusion and empyema. Respiration. 2008, 75:241-250.
46. Russel M.L., Gladman D.D., Mintz S. Rheumatoid pleural effusion: lack of response to intrapelural corticosteroids. J Rheumatol. 1986, 13:412-415.
47. Crisp A.J., Armstrong R.D., Grahame R., Dussek J.E. Rheumatoid lung disease, pneumothorax, and eosinophilia. Ann Rheum Dis. 1982, 41:137-140.
48. Pisetsky D.S., Gilkeson G., St Clair E.W. Systemic lupus erythematosus. Diagnosis and treatment. Med Clin North Am. 1997, 81:113-128.
49. Alarcon G.S., Friedman A.W., Straaton K.V., Moulds J.M., Lisse J., Bastian H.M., et al. Systemic lupus erythematosus in three ethnic groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort. LUpus in MInority populations: Nature vs. Nurture. Lupus. 1999, 8:197-209.
50. Kamen D.L., Strange C. Pulmonary manifestations of systemic lupus erythematosus. Clin Chest Med. 2010, 31:479-488.
51. Mochizuki T., Aotsuka S., Satoh T. Clinical and laboratory features of lupus patients with complicating pulmonary disease. Respir Med. 1999, 93:95-101.
52. Bouros D., Pneumatikos I., Tzouvelekis A. Pleural involvement in systemic autoimmune disorders. Respiration. 2008, 75:361-371.
53. Sarwar A., Dellaripa P.F., Beamis J.F. A 51-year-old man with fever, ulnar neurophaty, and bilateral pleural effusions. Lupus pleuritis. Chest. 1999, 116:1105-1107.
54. Chandrasekhar A.J., Robinson J., Barr L. Antibody deposition in the pleura: a finding in drug induced lupus. J Allergy Clin Immunol. 1978, 61:399-402.
55. Good J.T., King T.E., Antony V.B., Sahn S.A. Lupus pleuritis: clinical features and pleural fluid characteristics with special reference to pleural fluid antinuclear antibodies. Chest. 1983, 84:714-718.
56. Keane M.P., Lynch J.P. Pleuropulmonary manifestations of systemic lupus erythematosus. Thorax. 2000, 55:156-159.
57. Wang D.Y., Yang P.C., Yu W.L., Kuo S.H., Hsu N.Y. Serial antinuclear antibodies titre in pleural and pericardial fluid. Eur Respir J. 2000, 15:1106-1110.
58. Khare V., Baethge B., Lang S., Wolf R.E., Campbell D.C. Antinuclear antibodies in pleural fluid. Chest. 1994, 106:866-871.
59. Leventhal L.J., DeMarco D.M., Zurier R.B. Antinuclear antibodies in pericardial fluid from a patient with primary cardiac lymphoma. Arch Intern Med. 1990, 150:1113-1115.
60. Maskell N.A., Butland R.J. Standards of Care Committee. British Thoracic Society. BTS Guidelines for the investigation of a unilateral pleural effusion in adults. Thorax. 2003, 58:ii8-ii17. Pleural Diseases Group.
61. Blomgren S.E., Condemi J.J., Vaughan J.H. Procainamide induced lupus erythematosus: clinical and laboratory observations. Am J Med. 1972, 52:338-348.
62. Swigris J.J., Fischer A., Gillis J., Meehan R.T., Brown K.K. Pulmonary and thrombotic manifestations of systemic lupus erythematosus. Chest. 2008, 133:271-280.
63. Kaine J.L. Refractory massive pleural effusion in systemic lupus erythematosus. Ann Rheum Dis. 1988, 47:1031-1032.
64. McKnight K.M., Adair N.E., Agudelo C.A. Successful use of tetracycline pleurodesis to treat massive pleural effusion secondary to systemic lupus erythematosus. Arthritis Reum. 1991, 34:1483-1484.
65. Ben-Chetrit E., Putterman C., Naparstek Y. Lupus refractory pleural effusion: transient response to intravenous immunoglobulins. J Rheumatol. 1991, 18:1635-1637.
66. Elsborn J.S., Conn P., Roberts S.D. Refractory massive pleural effusion in systemic lupus erythematosus treated by pleurectomy. Ann Rheum Dis. 1987, 46:77-80.
67. Kolosi M., Riemer E.C., Highland K.B. Pulmonary involvement in Sjögren syndrome. Clin Chest Med. 2010, 31:489-500.
68. Vitali C., Bombardieri S., Jonsson R., Moutsopoulos H.M., Alexander E.L., Carsons S.E., et al. Classification criteria for Sjögrenós syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002, 61:354-361. European Study Group on Classification Criteria for Sjögren's Syndrome.
69. Kawamata K., Haraoka H., Hirohata S., Hashimoto T., Jenkins R.N., Lipsky P.E. Pleurisy in primary Sjögren syndrome: T-cell receptor beta chain variable region gene bias and local autoimmunity production in the pleural effusion. Clin Exp Rheumatol. 1996, 35:72-75.
70. Horita Y., Miyazaki M., Kadota J., Watanabe T., Yamashita M., Nishiura K., et al. Type II diabetes mellitus and primary Sjögren syndrome complicated by pleural effusion. Intern Med. 2000, 39:979-984.
71. Mayes M.D., Lacey J.V., Beebe-Dimmer J., Gillespie B.W., Cooper B., Laing T.J., et al. Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum. 2003, 48:2246-2255.
72. Hant F.N., Herpel L.B., Silver R.M. Pulmonary manifestations of scleroderma and mixed connective tissue disease. Clin Chest Med. 2010, 31:433-449.
73. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for sclerodermia criteria of the American Rheumatism Association diagnostic and therapeutic criteria committee. Arthritis Rheum. 1980;23:581-90..
74. LeRoy E.C., Black C., Fleischmajer R., Jablonska S., Krieg T., Medsger T.A., et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988, 15:202-205.
75. Taormina V.J., Miller W.T., Gefter W.B., Epstein D.M. Progressive systemic sclerosis subgroups: variable pulmonary features. AJR Am J Roentgenol. 1981, 137:277-285.
76. Thompson A.E., Pope J.E. A study of the frequency of pericardial and pleural effusion in scleroderma. Br J Rheumatol. 1998, 37:1320-1323.
77. Singsen D.H., Tedford J.C., Platzker A.C.G., Hanson V. Spontaneous pneumothorax: a complication of juvenile dermatomyosistis. J Pediatr. 1978, 92:771-774.
78. Brock R.C. Recurrent and chronic spontaneous pneumothorax. Thorax. 1984, 3:88-111.
79. Ng S.C., Tan W.C. Bilateral spontaneous pneumothorax in systemic sclerosis: report of two cases. J Rheumatol. 1990, 17:689-691.
80. Sharp G.C., Irwin E.M., Gould R.G., Holman H.R. Mixed connective tissue disease: an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med. 1972, 52:148-159.
81. Silver T.M., Faber S.J., Bole G.B., Martel W. Radiological features of mixed connective tissue disease and scleroderma-systemic lupus erythematosus overlap. Radiology. 1976, 120:269-275.
82. Prakash U.B. Respiratory complications in mixed connective tissue disease. Clin Chest Med. 1998, 19:733-746.
83. Prakash U.B., Luthra H.S., Divertie M.B. Intrathoracic manifestations in mixed connective tissue disease. Mayo Clin Proc. 1985, 60:813-821.
84. Hoogsteden H.C., Van Dongen J.J.M., Van der Kwast T.H., Hooijkaas H., Hilvering C. Bilateral exudative pleuritis: an unusual pulmonary onset of mixed connective tissue disease. Respiration. 1985, 48:164-167.
85. Kanathur N., Lee-Chiong T. Pulmonary manifestations of ankylosing spondylitis. Clin Chest Med. 2010, 31:547-554.
86. Tanoue L.T. Pulmonary involvement in collagen vascular disease: a review of the pulmonary manifestations of the Marfan syndrome, ankylosing spondylitis, Sjögren's syndrome, and relapsing polychondritis. J Thorac Imaging. 1992, 7:62-77.
87. Rosenow E.C., Strimlan C.V., Muhm J.R., Ferguson R.H. Pleuropulmonary manifestations of ankilosing spondylitis. Mayo Clin Proc. 1977, 52:641-649.
88. Nagyhegyi G., Nadas I., Banyai F., Luzsa G., Geher P., Molnar J., et al. Cardiac and cardiopulmonary disorders in patients with ankylosing spondylitis and rheumatoid arthritis. Clin Exp Rheumatol. 1988, 6:17-26.
89. Sahn S.A. Pathogenesis of pleural effusions and pleural lesions. The lung in rheumatic disease 1990, 27-45. Marcel Dekker, New York. G.W. Cannon, G.A. Zimmermann (Eds.).
90. Kinnear W.M.J., Shneerson J.M. Acute pleural effusion in inactive ankylosing spondylitis. Thorax. 1985, 40:150-151.
91. Tanaka H., Itoh E., Shibusa T., Chiba H., Hirasawa M., Abe S. Pleural effusion in ankylosing spondilitis: successful treatment with intra-pleural steroid administration. Respir Med. 1985, 89:509-511.
92. Ignacio García J.M., Hita Pérez J., García Mendoza A., Alonso Atienza P., Miramón López J. Eosionofilia periférica y derrame pleural eosinofílico en un paciente con espondilitis anquilosante. Arch Bronconeumol. 1987, 23:156-157.
93. Libshitz H.I., Atkinso G.W., Isreal H. Pleural thickening as a manifestation of Aspergillus superinfection. AJR. 1974, 120:883-886.
94. Lee C.C., Lee S.H., Chang I.J., Lu T.C., Yuan A., Chang T.A., et al. Spontaneous pneumothorax associated with ankylosing spondylitis. Rheumatology. 2005, 44:1538-1541.
95. Wang C.T., Tsen J.C., Lin H.J., Cheng H.H. Bilateral spontaneous pneumothorax in a patient with ankylosing spondylitis. Eur J Emerg Med. 2007, 14:123-124.
96. Kalluri M., Oddis C.V. Pulmonary manifestations of the idiopathic inflammatory myopathies. Clin Chest Med. 2010, 31:501-512.
97. Dalakas M.C., Hohlfeld R. Polymyositis and dermatomyositis. Lancet. 2003, 362:971-982.
98. Torres C., Belmonte R., Carmona L., Gómez-Reino F.J., Galindo M., Ramos B., et al. Survival, mortality and causes of death in inflammatory myopathies. Autoimmunity. 2006, 39:205-215.
99. Miyata M., Fukaya E., Takagi T., Watanabe K., Saito H., Ito M., et al. Two patients with polymyositis or dermatomyositis complicated with massive pleural effusion. Intern Med. 1998, 37:1058-1063.
100. Dickey B.F., Myers A.R. Pulmonary disease in polymyositis/dermatomyositis. Semin Arthritis Rheum. 1984, 14:60-76.
101. Piura B., Meirovitz M., Cohen Y., Horowitz J. Dermatomyositis and peritoneal papillary serous carcinoma. Eur J Obstet Gynecol Reprod Biol. 1999, 82:93-96.
102. Le Goff B., Cherin P., Cantagrel A., Gayraud M., Hachulla E., Laborde F., et al. Pneumomediastinum in interstitial lung disease associated with dermatomyositis and polymyositis. Arthritis Rheum. 2009, 61:108-118.
103. Frankel S.K., Jayne D. The pulmonary vasculitides. Clin Chest Med. 2010, 31:519-536.
104. Reinhold-Keller E., Beuge N., Latza U., de Groot K., Rudert H., Nölle B., et al. An interdisciplinary approach to the care of patients with Wegener's granulomatosis. Arthritis Rheum. 2000, 43:1021.
105. Cordier J.F., Valeyre D., Guillevin L., Loire R., Brechot J.M. Pulmonary Wegener's granulomatosis: a clinical and imaging study of 77 cases. Chest. 1990, 97:906-912.
106. Bambery P., Sakhuja V., Behera D., Deodhar S.D. Pleural effusion in Wegener's granulomatosis: report of five patients and brief review of the literature. Scand J Rheumatol. 1991, 20:445-447.
107. Diot E., Lavigne C., Renjard L., Asquier E., Valentin J.F., Legras A., et al. Wegener's disease mimicking acute infectious pleurisy. Rev Pneumol Clin. 2000, 56:265-268.
108. Blundell A.G., Roe S. Wegener's granulomatosis presenting as a pleural effusion. BMJ. 2003, 327:95-96.
109. Wolffenbuttel B.H.R., Webber R.F.A., Kho G.S. Pyopneumothorax: a rare complication of Wegener's granulomatosis. Eur J Respir Dis. 1995, 67:223-227.
110. Lanham J., Elkon K., Pusey C., Hughes G.R. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine. 1984, 63:65-81.
111. Sinico R.A., Di Toma L., Maggiore U., Bottero P., Radice A., Tosoni C., et al. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome. Arthritis Rheum. 2005, 52:2926-2935.
112. Buschman D.L., Waldron J.A., King T.E. Churg-Strauss pulmonary vasculitis: high resolution computed tomography scanning and pathologic findings. Am Rev Respir Dis. 1990, 142:458-461.
113. Erzurum S.C., Underwood G.A., Hamilos D.L., Waldron J.A. Pleural effusion in Churg-Strauss syndrome. Chest. 1989, 95:1357-1359.
114. Sakane T., Takeno M., Suzuki N., Inaba G. Behçet disease. N Engl J Med. 1999, 341:1284-1291.
115. Criteria for diagnosis of Behçet disease's. Lancet. 1990, 335:1078-1080. International Study Group for Behçet disease.
116. Raz I., Okon E., Chajek-Shaul T. Pulmonary manifestations in Behçet's syndrome. Chest. 1989, 95:585-589.
117. Kansu E., Ozer F.L., Akalin E., Guler Y., Zileli T., Tanman E., et al. Behçet's síndrome with obstruction of the venae cavae. A report of seven cases. Q J Med. 1972, 41:151-168.
118. Coplu L., Emri S., Selcuk Z.T., Kalyoncu F., Balkanci F., Sahin A.A., et al. Life threatening chylous pleural and pericardial effusion in patient with Behçet syndrome. Thorax. 1992, 47:64-65.
119. Husain S.J., Sadiq F., Zubairi A.B., Khan J.A. Massive unilateral chylous pleural effusion: a rare initial presentation of Behçet's disease. Singapore Med J 2006, 47:978-980.
120. Warren W.H., Altman J.S., Gregory S.A. Chylothorax secondary to obstruction of the superior vena cava: a complication of the LeVeen shunt. Thorax. 1990, 45:978-979.
121. Roguin A., Edelstein S., Edoute Y. Superior vena cava syndrome as a primary manifestation of Behcet's disease. A case report. Angiology. 1997, 48:365-368.
122. Hunninghake G.W., Costabel U., Ando M., Baughman R., Cordier J.F., du Bois R., et al. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis. 1999, 16:149-173. ATS/ERS/WASOG statement on sarcoidosis.
123. Morgenthau A.S., Iannuzzi M.C. Recent advances in sarcoidosis. Chest. 2011, 139:174-182.
124. Fernández Fabrellas E. Epidemiología de la sarcoidosis. Arch Bronconeumol. 2007, 43:92-100.
125. Huggins J.T., Doelken P., Sahn S.A., King L., Judson M.A. Pleural effusions. In a series of 181 outpatients with sarcoidosis. Chest. 2006, 129:1599-1604.
126. Soskel N.T., Sharma O.P. Pleural involvement in sarcoidosis. Curr Opin Pulm Med. 2000, 6:455-468.
127. Szwarcberg J.B., Glajchen N., Teirstein A.S. Pleural involvement in chronic sarcoidosis detected by thoracic CT scanning. Sarcoidosis Vasc Diffuse Lung Dis. 2005, 22:58-62.
128. Heidecker J.T., Judson M.A. Pleural effusion caused by a trapped lung. South Med J. 2003, 96:510-511.
129. Kumar S., Verma S.K., Singh R., Prasad R. Hemorrhagic pleural effusion secondary to sarcoidosis: a brief review. Ann Thorac Med. 2009, 4:27-31.
130. Sharma O.P., Gordonosn J. Pleural effusion in sarcoidosis: a report of six cases. Thorax. 1975, 30:95-101.
131. Wilen S.B., Rabinowitz J.G., Ulreich S., Lyons H.A. Pleural involvement in sarcoidosis. Am J Med. 1974, 57:200-209.
132. Durand D.V., Dellinger A., Guerin C., Guerin J.C., Levrat R. Pleural sarcoidosis: one case presenting with an eosinophilic effusion. Thorax. 1984, 39:468-469.
133. Groman G.S., Castele R.J., Altose M.D., Scillian J., Kleinhenz M.E., Ehlers R. Lymphocyte subpopulations in sarcoid pleural effusion. Ann Intern Med. 1984, 100:75-77.
134. Johnson N.M., Martin N.D.T., McNicol M.W. Sarcoidosis presenting with pleurisy and bilateral pleural effusions. Postgrad Med J. 1980, 56:266-267.
135. Wu R.G., Yang P.C., Kuo S.H., Luh K.T. Fluid color" sign: a useful indicator for discriminating between pleural thickening and pleural effusion. J Ultrasound Med. 1995, 14:767-768.
136. Eosinophilia-myalgia syndrome - New Mexico. MMWR. 1989, 38:765-767. Centers for Disease Control.
137. Hertzman P.A., Blevins W.L., Mayer J., Greenfield B., Ting M., Gleich G. Association of the eosinophilia-myalgia syndrome with the ingestion of tryptophan. N Engl J Med. 1990, 322:869-873.
138. Swygert L.A., Maes E.F., Sewell L.E., Miller L., Falk H., Kilbourne E.M. Eosinophilia-myalgia syndrome. Results of national surveillance. JAMA. 1990, 264:1698-1703.
139. Williamson M.R., Eidson M., Rosenberg R.D., Williamson S.L. Eosinophilia-myalgia syndrome: findings on chest radiographs in 18 patients. Radiology. 1991, 180:849-852.
140. Shulman L.E. Diffuse fasciitis with eosinophilia: a new syndrome? Trans Assoc Am Physicians. 1975, 88:70-86.
141. Lakhanpal S., Ginsburg W.W., Michet C.J., Doyle J.A., Moore S.B. Eosinophilic fasciitis: clinical spectrum and therapeutic response in 52 cases. Semin Arthritis Rheum. 1998, 17:221-231.
142. Killen J.W.W., Swift G.L., White R.J. Eosinophilic fasciitis with pulmonary and pleural involvement. Postgrad Med J. 2000, 76:36-37.
143. Dogan A., Gaulard P., Jaffe E.S., Ralfkiaer E., Müller-Hermelink H.K. Angioimmunoblastic T-cell lymphoma. Pathology and genetics of tumours of haematopoietic and lymphoid tissues: World Health Organization classification of tumours. 2008, 309-311. IARC Press, Lyon, France. 4th ed. S.H. Swerdlow, E. Campo, N.L. Harris (Eds.).
144. Cullen M.H., Stansfeld A.G., Oliver R.T.D., Lister T.A., Malpas J.S. Angio-immunoblastic lymphadenopathy: report of ten cases and review of the literature. Q J Med. 1979, 189:151-177.
145. Sugiyama H., Kotajima F., Kamimura M., Yoshizawa A., Hojo M., Horiuchi T., et al. Pulmonary involvement in immunoblastic lymphadenopaty: case reports and review of literature published in Japan. Nihon Kyobu Shikkan Gakkai Zasshi. 1995, 33:1276-1282.
146. Gonzalez-Gay M.A., Garcia-Porrua C. Epidemiology of the vasculitides. Rheum Dis Clin North Am. 2001, 27:729-749.
147. Salvarani C., Cantini F., Boiardi L., Hunder G.G. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med. 2002, 347:261-271.
148. Larson T.S., Hall S., Hepper N.G.G., Hunder G.G. Respiratory tract symptoms as a clue to giant cell arteritis. Ann Intern Med. 1984, 101:594-597.
149. Romero S., Vela P., Padilla I., Rosas J., Martín C., Aranda I. Pleural effusion as manifestation of temporal arteritis. Thorax. 1992, 47:398-399.
150. Ramos A., Laguna P., Cuervas V. Pleural effusion in giant cell arteritis. Ann Intern Med. 1992, 116:957.
151. García-Alfranca F., Solans R., Simeón C., Gómez-Lozano A., Pérez-Bocanegra C., Bosch J.A. Pleural effusion as a form of presentation of temporal arteritis. Br J Rheumatol. 1998, 37:203-802.
152. Gur H., Ehrenfeld M., Izsak E. Pleural effusion as a presenting manifestation of giant cell arteritis. Clin Rheumatol. 1996, 15:200-203.
153. Burns J.C. The riddle of Kawasaki disease. N Engl J Med. 2007, 356:659-661.
154. Umezawa T., Saji T., Matsuo N., Odagiri K. Chest x-ray findings in the acute phase of Kawasaki disease. Pediatr Radiol. 1989, 20:48-51.
155. Amano S., Hazama F., Kubagawa H., Tasaka K., Haebara H., Hamashima Y. General pathology of Kawasaki disease on the morphological alterations corresponding to the clinical manifestation. Acta Pathol Jpn. 1980, 30:681-694.
156. Kumagai Y., Abe C., Shiokawa Y. Scleroderma after cosmetic surgery - four cases of human adjuvant disease. Arthritis Rheum. 1979, 22:532-537.
157. Walsh F.W., Solomon D.A., Espinoza L.R., Adams G.D., Whitelocke H.E. Human adjuvant disease. A new cause of chylous effusions. Arch Intern Med. 1989, 149:1194-1196.
158. Kontzias A., Efthimiou P. Adult-onset Still's disease: pathogenesis, clinical manifestations and therapeutic advances. Drugs. 2008, 68:319-337.
159. Mueller R.B., Sheriff A. Scoring adult-onset Still's disease. J Rheumatol. 2010, 37:2203-2204.
160. Pouchot J., Sampalis J.S., Beaudet F., Carette S., Décary F., Salusinsky-Sternbach M., et al. Adult Still's disease: manifestations, disease course, and outcome in 62 patients. Medicine (Baltimore). 1991, 70:118-136.
161. Pasteur M., Laroche C., Keogan M. Pleuropericardial effusion in a 50 year old woman. Postgrad Med J. 2001, 77:355-357.
162. Lightfoot R.W., Michel B.A., Bloch D.A., Hunder G.G., Zvaifler N.J., McShane D.J., et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum. 1990, 33:1088-1093.
163. Pagnoux C., Seror R., Henegar C., Mahr A., Cohen P., Le Guern V., et al. Clinical features and outcomes in 348 patients with polyarteritis nodosa. A systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the french vasculitis study group database. Arthritis Rheum. 2010, 62:616-626.
164. Leavitt R.Y., Fauci A.S. Polyangiitis overlap syndrome. Classification and prospective clinical experience. Am J Med. 1986, 81:79-85.
165. Koarada S., Tada Y., Aihara S., Ushiyama O., Suzuki N., Ohta A., et al. Polyangiitis overlap síndrome with eosinophilia associated with a elevated serum level of major basic protein. Intern Med. 1999, 38:739-743.